Tylenol's brand reputation has largely bounced back without permanent damage after attacks from the Trump administration, ...

Tylenol’s brand reputation has bounced back among Republicans after suffering a blow following President Trump’s warning last ...

Kimberly-Clark CEO Mike Hsu told CNBC's Jim Cramer that his company's acquisition of Tylenol maker Kenvue will create value for shareholders, even as the pain reliever is scrutinized by the Trump ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Kimberly-Clark is making a big move with a nearly $50 billion deal, putting it among the biggest companies in the health and wellness market. The North Texas company plans to acquire Kenvue Inc., a ...

A huge range of popular brand-name products from food to pharmaceuticals, including Cheerios and Tylenol, were recalled last ...

Infants given acetaminophen (also called paracetamol; brand name, Tylenol) for pain or fever relief in their first year were ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...